Skip to main content
https://pbs.twimg.com/media/F-cLyi0XMAATIPI.jpg
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved to be effective and without potentially allergic lung reactions. https://t.co/MRFwrCXIlQ https://t.co/Su3nMs4CNW
Dr. John Cush
08-11-2023
×